-
1
-
-
0037698889
-
Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests?
-
Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology 37, 972-974 (2003).
-
(2003)
Hepatology
, vol.37
, pp. 972-974
-
-
Afdhal, N.H.1
-
2
-
-
0036830347
-
The role of liver biopsy in chronic hepatitis C
-
Dienstag J. The role of liver biopsy in chronic hepatitis C. Hepatology 36, S152-S160 (2002).
-
(2002)
Hepatology
, vol.36
-
-
Dienstag, J.1
-
4
-
-
0036792679
-
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
-
Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 97, 2614-2618 (2002).
-
(2002)
Am. J. Gastroenterol.
, vol.97
, pp. 2614-2618
-
-
Regev, A.1
Berho, M.2
Jeffers, L.J.3
-
5
-
-
0042671303
-
Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease
-
Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J. Hepatol. 39, 239-244 (2003).
-
(2003)
J. Hepatol.
, vol.39
, pp. 239-244
-
-
Colloredo, G.1
Guido, M.2
Sonzogni, A.3
Leandro, G.4
-
6
-
-
0345017740
-
Sampling variability of liver fibrosis in chronic hepatitis C
-
Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38, 1449-1457 (2003).
-
(2003)
Hepatology
, vol.38
, pp. 1449-1457
-
-
Bedossa, P.1
Dargère, D.2
Paradis, V.3
-
8
-
-
0042766810
-
Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon α-2b and ribavirin
-
Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon α-2b and ribavirin. Hepatology 38, 481-492 (2003).
-
(2003)
Hepatology
, vol.38
, pp. 481-492
-
-
Poynard, T.1
McHutchison, J.2
Manns, M.3
Myers, R.P.4
Albrecht, J.5
-
9
-
-
3242798959
-
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C
-
Poynard T, Munteanu M, Imbert-Bismut F et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin. Chem. 50, 1344-1355 (2004).
-
(2004)
Clin. Chem.
, vol.50
, pp. 1344-1355
-
-
Poynard, T.1
Munteanu, M.2
Imbert-Bismut, F.3
-
10
-
-
0036829484
-
Role of liver biopsy in management of chronic hepatitis C: A systematic review
-
Gebo KA, Herlong HF, Torbenson MS et al. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36, S161-S172 (2002).
-
(2002)
Hepatology
, vol.36
-
-
Gebo, K.A.1
Herlong, H.F.2
Torbenson, M.S.3
-
11
-
-
0035820265
-
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study
-
Imbert-Bismut F, Ratziu V, Laurence Pieroni L et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357, 1069-1075 (2001).
-
(2001)
Lancet
, vol.357
, pp. 1069-1075
-
-
Imbert-Bismut, F.1
Ratziu, V.2
Laurence Pieroni, L.3
-
12
-
-
0036906034
-
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: Longitudinal validation in a randomized trial
-
Poynard T, Imbert-Bismut F, Ratziu V et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J. Viral Hepatitis 9, 128-133 (2002).
-
(2002)
J. Viral Hepatitis
, vol.9
, pp. 128-133
-
-
Poynard, T.1
Imbert-Bismut, F.2
Ratziu, V.3
-
13
-
-
0036734486
-
Biochemical markers of liver fibrosis: A comparison with historical features in patients with chronic hepatitis C
-
Myers RP, Ratziu V, Imbert-Bismut F, Charlotte F, Poynard T. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C. Am. J. Gastroenterol. 97, 2419-2425 (2002).
-
(2002)
Am. J. Gastroenterol.
, vol.97
, pp. 2419-2425
-
-
Myers, R.P.1
Ratziu, V.2
Imbert-Bismut, F.3
Charlotte, F.4
Poynard, T.5
-
14
-
-
0037471273
-
Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus-coinfected patients
-
Myers RP, Benhamou Y, Imbert-Bismut F et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus-coinfected patients. AIDS 17, 1-5 (2003).
-
(2003)
AIDS
, vol.17
, pp. 1-5
-
-
Myers, R.P.1
Benhamou, Y.2
Imbert-Bismut, F.3
-
15
-
-
0037280482
-
Biochemical markers of fibrosis in patients with chronic hepatitis C: A comparison with prothrombin time, platelet count and the age-platelet index
-
Myers RP, de Torres M, Imbert-Bismut F, Ratziu V, Charlotte F, Poynard T. Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count and the age-platelet index. Dig. Dis. Sci. 48, 146-153 (2003).
-
(2003)
Dig. Dis. Sci.
, vol.48
, pp. 146-153
-
-
Myers, R.P.1
De Torres, M.2
Imbert-Bismut, F.3
Ratziu, V.4
Charlotte, F.5
Poynard, T.6
-
16
-
-
85081151208
-
Non-invasive prediction of fibrosis in patients with chronic hepatitis C
-
Thabut D, Simon M, Myers RP et al. Non-invasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology 37, 1220-12221 (2003).
-
(2003)
Hepatology
, vol.37
, pp. 1220-12221
-
-
Thabut, D.1
Simon, M.2
Myers, R.P.3
-
17
-
-
1542724800
-
Fibrotest has higher predictive values than APRI for fibrosis diagnosis in patients with chronic hepatitis C
-
LeCalvez S, Thabut D, Messous D et al. Fibrotest has higher predictive values than APRI for fibrosis diagnosis in patients with chronic hepatitis C. Hepatology 39, 862-863 (2004).
-
(2004)
Hepatology
, vol.39
, pp. 862-863
-
-
LeCalvez, S.1
Thabut, D.2
Messous, D.3
-
18
-
-
0042553522
-
A prospective assessment of the interlaboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease
-
Halfon P, Imbert-Bismut F, Messous D et al. A prospective assessment of the interlaboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease. Comp. Hepatol. 1, 3-7 (2002).
-
(2002)
Comp. Hepatol.
, vol.1
, pp. 3-7
-
-
Halfon, P.1
Imbert-Bismut, F.2
Messous, D.3
-
19
-
-
0037371363
-
Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients
-
Rossi E, Adams L, Prins A et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin. Chem. 49, 450-454 (2003).
-
(2003)
Clin. Chem.
, vol.49
, pp. 450-454
-
-
Rossi, E.1
Adams, L.2
Prins, A.3
-
20
-
-
0141480785
-
Fibrotest even better than liver biopsy?
-
Electronic letter. Response: (21 March 2003)
-
Poynard T, Imbert-Bismut F, Ratziu V et al. Fibrotest even better than liver biopsy? Clin. Chem. 2003. Electronic letter http://www.clinchem.org/cgi/ eletters/49/3/450. Response: (21 March 2003)
-
(2003)
Clin. Chem.
-
-
Poynard, T.1
Imbert-Bismut, F.2
Ratziu, V.3
-
21
-
-
0141869032
-
Cost effectiveness of pegylated interferon α2b and ribavirin combination in chronic hepatitis C
-
Poynard T. Cost effectiveness of pegylated interferon α2b and ribavirin combination in chronic hepatitis C. Gut 52, 1532 (2003).
-
(2003)
Gut
, vol.52
, pp. 1532
-
-
Poynard, T.1
-
22
-
-
11144355931
-
Intra-laboratory analytical variability of biochemical markers of fibrosis (FibroTest) and activity (Actitest) and reference ranges in healthy blood donors
-
Imbert-Bismut F, Messous D, Thibaut V et al. Intra-laboratory analytical variability of biochemical markers of fibrosis (FibroTest) and activity (Actitest) and reference ranges in healthy blood donors. Clin. Chem. Lab. Med. 42(3) 323-333 (2004).
-
(2004)
Clin. Chem. Lab. Med.
, vol.42
, Issue.3
, pp. 323-333
-
-
Imbert-Bismut, F.1
Messous, D.2
Thibaut, V.3
-
23
-
-
13644263674
-
Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (Fibrotest) and activity (Actitest)
-
Munteanu M, Messous D, Thabut D et al. Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (Fibrotest) and activity (Actitest). Comp. Hepatol. 3, 3 (2004).
-
(2004)
Comp. Hepatol.
, vol.3
, pp. 3
-
-
Munteanu, M.1
Messous, D.2
Thabut, D.3
-
25
-
-
12344267742
-
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV-FibtoSURE) and necrosis (ActiTest) in patients with chronic hepatitis C
-
Poynard T, Imbert-Bismut F, Munteanu M et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV-FibtoSURE) and necrosis (ActiTest) in patients with chronic hepatitis C Comp. Hepatol. Comp. Hepatol. 3, 8 (2004).
-
(2004)
Comp. Hepatol. Comp. Hepatol.
, vol.3
, pp. 8
-
-
Poynard, T.1
Imbert-Bismut, F.2
Munteanu, M.3
-
26
-
-
1942454310
-
Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics
-
Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nature Med. 10, 1-6 (2004).
-
(2004)
Nature Med.
, vol.10
, pp. 1-6
-
-
Callewaert, N.1
Van Vlierberghe, H.2
Van Hecke, A.3
Laroy, W.4
Delanghe, J.5
Contreras, R.6
-
27
-
-
10844238015
-
Independent prospective multicenter validation of biochemical markers (FibroTest-ActiTest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C
-
Halfon P, Bourliere M, Deydier R et al. Independent prospective multicenter validation of biochemical markers (FibroTest-ActiTest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C. Hepatology 38, 188A (2003).
-
(2003)
Hepatology
, vol.38
-
-
Halfon, P.1
Bourliere, M.2
Deydier, R.3
-
28
-
-
12344269845
-
Comparision of usefulness and accuracy of simple noninvasive models as predictors of cirrhosis in chronic hepatitis
-
Borroni G, Cazzaniga M, Ceriani R et al. Comparision of usefulness and accuracy of simple noninvasive models as predictors of cirrhosis in chronic hepatitis. J. Hepatol. 40, 137 (2004).
-
(2004)
J. Hepatol.
, vol.40
, pp. 137
-
-
Borroni, G.1
Cazzaniga, M.2
Ceriani, R.3
-
29
-
-
4544274791
-
FIBROSpect II: A potential noninvasive test to assess hepatic fibrosis
-
Poordad FF. FIBROSpect II: a potential noninvasive test to assess hepatic fibrosis. Expert Rev. Mol. Diagn. 4, 593-597 (2004).
-
(2004)
Expert Rev. Mol. Diagn.
, vol.4
, pp. 593-597
-
-
Poordad, F.F.1
-
30
-
-
0003179169
-
Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C
-
The METAVIR co-operative group. Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. Hepatology 20(1), 15-20 (1994).
-
(1994)
Hepatology
, vol.20
, Issue.1
, pp. 15-20
-
-
-
31
-
-
0029778988
-
An algorithm for the grading of activity in chronic hepatitis C
-
The METAVIR Co-operative Study Group
-
Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Co-operative Study Group. Hepatology 24, 289-293 (1996).
-
(1996)
Hepatology
, vol.24
, pp. 289-293
-
-
Bedossa, P.1
Poynard, T.2
-
32
-
-
10744221863
-
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B
-
Myers RP, Tainturier MH, Ratziu V et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J. Hepatol. 39, 222-230 (2003).
-
(2003)
J. Hepatol.
, vol.39
, pp. 222-230
-
-
Myers, R.P.1
Tainturier, M.H.2
Ratziu, V.3
-
33
-
-
12344335496
-
The diagnostic value of biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease
-
In Press
-
Naveau S, Raynard B, Ratziu V et al. The diagnostic value of biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin. Gastroenterol. Hepatol. (2005) (In Press).
-
(2005)
Clin. Gastroenterol. Hepatol.
-
-
Naveau, S.1
Raynard, B.2
Ratziu, V.3
-
34
-
-
12344337297
-
Diagnostic value of biochemical markers (FibroTest) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
-
Ratziu V, Lecalvez S, Imbert-Bismut F et al. Diagnostic value of biochemical markers (FibroTest) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Hepatology 38, 510A (2003).
-
(2003)
Hepatology
, vol.38
-
-
Ratziu, V.1
Lecalvez, S.2
Imbert-Bismut, F.3
-
35
-
-
3242768719
-
Diagnostic value of fibrosis biochemical markers (FibroTest) for the prediction of portal hypertension in liver disease
-
Thabut D, Imbert-Bismut F, Cazals-Athem D et al. Diagnostic value of fibrosis biochemical markers (FibroTest) for the prediction of portal hypertension in liver disease. Hepatology 38, 282A (2003).
-
(2003)
Hepatology
, vol.38
-
-
Thabut, D.1
Imbert-Bismut, F.2
Cazals-Athem, D.3
-
36
-
-
3242800803
-
Diagnostic value of fibrosis biochemical markers (FibroTest) for the screening of oesophageal varices in patients with chronic liver disease
-
Thabut D, Trabut JB, Le Calvez S et al. Diagnostic value of fibrosis biochemical markers (FibroTest) for the screening of oesophageal varices in patients with chronic liver disease. Hepatology 38, 284A (2003).
-
(2003)
Hepatology
, vol.38
-
-
Thabut, D.1
Trabut, J.B.2
Le Calvez, S.3
-
38
-
-
12344309018
-
Prospective comparison of transient elastography, fibrotest, apri and liver biopsy for the assessment of fibrosis in chronic hepatitis C
-
In Press
-
Castera L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, fibrotest, apri and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology (2005) (In Press).
-
(2005)
Gastroenterology
-
-
Castera, L.1
Vergniol, J.2
Foucher, J.3
-
39
-
-
4544236421
-
Noninvasive diagnosis of fibrosis in chronic liver disease
-
Lichtinghagen R, Bahr MJ. Noninvasive diagnosis of fibrosis in chronic liver disease. Expert Rev. Mol. Diagn. 4, 715-726 (2004).
-
(2004)
Expert Rev. Mol. Diagn.
, vol.4
, pp. 715-726
-
-
Lichtinghagen, R.1
Bahr, M.J.2
|